Is BrightGene Bio-Medical Technology (SHSE:688166) Using Too Much Debt?

Simply Wall StApr 25 19:42 ET

Borui Pharmaceuticals: Report for the first quarter of 2025

SZSIApr 17 12:00 ET · Announcements

2025 First Quarter Report

SZSIApr 17 12:00 ET · Announcements

Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.

In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.

cls.cnApr 6 20:17 ET

BrightGene Bio-Medical Technology Co., Ltd.'s (SHSE:688166) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?

Simply Wall StApr 4 18:35 ET

Borui Pharmaceuticals: 2024 Annual Report Summary

SZSIApr 2 12:00 ET · Announcements